184 related articles for article (PubMed ID: 23009777)
1. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence.
Maki KC; Bays HE; Dicklin MR
J Clin Lipidol; 2012; 6(5):413-26. PubMed ID: 23009777
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
3. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia and cardiovascular risk reduction.
Jacobson TA; Miller M; Schaefer EJ
Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
[TBL] [Abstract][Full Text] [Related]
5. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with statins and omega-3 fatty acids.
Nambi V; Ballantyne CM
Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
[TBL] [Abstract][Full Text] [Related]
7. Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects.
Roth EM; Bays HE; Forker AD; Maki KC; Carter R; Doyle RT; Stein EA
J Cardiovasc Pharmacol; 2009 Sep; 54(3):196-203. PubMed ID: 19597368
[TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridemia: the importance of identifying patients at risk.
Kushner PA; Cobble ME
Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia: management of atherogenic dyslipidemia.
Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
[TBL] [Abstract][Full Text] [Related]
10. Addressing lipid treatment targets beyond cholesterol: a role for prescription omega-3 fatty acid therapy.
Dall TL; Bays H
South Med J; 2009 Apr; 102(4):390-6. PubMed ID: 19279539
[TBL] [Abstract][Full Text] [Related]
11. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia: management using optimal lipid-lowering therapy.
Ito MK
Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
[TBL] [Abstract][Full Text] [Related]
14. Management of dyslipidemia in the high-risk patient.
Stein EA
Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
16. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides.
Sadovsky R; Kris-Etherton P
Postgrad Med; 2009 Jul; 121(4):145-53. PubMed ID: 19641280
[TBL] [Abstract][Full Text] [Related]
17. Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
Watts GF; Karpe F
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):987-97. PubMed ID: 21878044
[TBL] [Abstract][Full Text] [Related]
18. Severe hypertriglyceridemia-related acute pancreatitis.
Stefanutti C; Labbadia G; Morozzi C
Ther Apher Dial; 2013 Apr; 17(2):130-7. PubMed ID: 23551669
[TBL] [Abstract][Full Text] [Related]
19. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
20. A physician's guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy.
Klop B; Wouter Jukema J; Rabelink TJ; Castro Cabezas M
Panminerva Med; 2012 Jun; 54(2):91-103. PubMed ID: 22525564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]